Resources for Researchers

All NIDDK Standardization Programs







C-peptide Standardization


Clinical trials of agents to preserve beta cell function in new onset type 1 diabetes will use C-peptide as an outcome measure that indicates insulin production. The C-peptide standardization program is supported to establish reliability in results and facilitate the conduct of international clinical trials.
For more information, contact Dr. Lisa Spain, DEM, Director, Immunobiology of Type 1 Diabetes Program and Autoimmune Endocrine Diseases Program


Creatinine Standardization Program, Laboratory Professionals
http://nkdep.nih.gov/labprofessionals/index.htm

The NKDEP Laboratory Working Group has launched the Creatinine Standardization Program to address inter-laboratory variation in creatinine assay calibration and provide more accurate estimates of GFR.
For more information, contact Dr. Andrew Narva, Director, National Kidney Disease Education Program; Senior Scientific Advisor


Diabetes Autoantibody Standardization Program (DASP)
http://www.idsoc.org/committees/antibody/dasphome.html

The fundamental aim of DASP is to improve the measurements of the autoantibodies predictive of type 1 diabetes.
For more information, contact Dr. Beena Akolkar, DEM, Director, Immunopathogenesis and Genetics of Type 1 Diabetes Program


National Glycohemoglobin Standardization Program (NGSP)
http://www.missouri.edu/~diabetes/ngsp.html

The goal of this project is to improve HbA1c measurements and data interpretation across clinical systems and national harmonization projects.


General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
Phone: 301.496.3583